May 24, 2021 / 12:00PM GMT
Matthew Charles Taylor - UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices
Great. All right. Good morning, everybody. This is Matt Taylor, UBS' U.S. medical supplies and devices analyst. And I'm pleased to be kicking off our Virtual Healthcare Conference in the medtech track. And today, we have management from TELA Bio joining us. We got Tony Koblish, the CEO, on the line.
And just to get everybody oriented for these sessions, most of them are geared to be a 45-minute fireside chat that will be moderated by me.
If you have any questions that you'd like to ask the management team or for us to ask them, please just send in an e-mail to me or any member of my team. And then we also have a way that you can submit questions through the webcast. So we can weave some of those into the conversation.
For this first session, this morning, it's going to be very much that format, except we're going to have a few opening comments from Tony talking about TELA, and we'll jump into the Q&A.
So I hope everybody has a great day and
TELA Bio Inc at UBS Global Healthcare Virtual Conference Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers